Endocrine cancerParathyroid Cancer
Section snippets
Epidemiology and Demographics
Parathyroid carcinoma is a rare cause of primary HPT. Early single-institution case series suggested that it was responsible for 2% to 5% of all cases,1, 2, 3 but these figures are likely overestimates resulting from referral and publication biases, and/or the use of variable diagnostic criteria. Data from the largest single-institution study, a comprehensive literature review, and recent tumor registries indicate that it accounts for less than 1% of all cases in most parts of the world.4, 5, 6
Etiology and Pathophysiology
The etiology of parathyroid cancer, like that of other malignancies, likely involves the interaction of multiple environmental and genetic factors. Exposure to radiation, especially during childhood, increases the risk of benign parathyroid disease,10, 11, 12 as well as concurrent thyroid and parathyroid neoplasia,13, 14, 15 but whether such exposure plays an etiologic factor in parathyroid carcinoma remains unclear. Case reports and retrospective identification of several cases of parathyroid
Clinical Presentation of Parathyroid Cancer
The clinical presentation of parathyroid carcinoma is usually related to symptoms caused by the effects of markedly elevated serum PTH and hypercalcemia, rather than mass effects due to local infiltration or distant metastases. Systemic symptoms of hypercalcemia include fatigue, weakness, weight loss, anorexia, nausea, vomiting, polyuria, polydipsia, and depression. Manifestations of hyperparathyroid bone disease include osteitis fibrosa cystica, subperiostial bone resorption, “salt and pepper”
Laboratory Testing and Imaging in Parathyroid Cancer
No single laboratory finding is diagnostic of parathyroid carcinoma, but certain findings may offer clues that it ought to be included in the differential diagnosis of a patient presenting with primary HPT. The typical serum calcium in parathyroid cancer patients at presentation reported in the last three decades is 14.6–15.0 mg/dL,3, 4, 72 and approximately 60% to 65% of patients present with a calcium level greater than 14 mg/dL.3, 4, 72 A subset of functional parathyroid cancers demonstrate
Surgical Findings
The diagnosis of parathyroid carcinoma is often suspected due to characteristic findings at the time of initial surgery. The tumor usually has a firm or hard consistency, is sometimes lobulated, and is usually surrounded by a dense fibrous capsule that gives it a white, grey-white, or grey-brown hue. Parathyroid carcinoma often adheres to and infiltrates adjacent structures.1, 84, 85 The most common sites of local invasion are the ipsilateral thyroid gland, strap muscles, ipsilateral recurrent
Diagnosis
In the absence of obvious metastatic disease the distinction between parathyroid carcinoma and adenoma is difficult using microscopic histopathologic criteria. The principal histologic features that distinguish parathyroid carcinoma from adenoma, identified by Schantz and Castleman based on their examination of 70 parathyroid cancers, were the presence of parenchymal mitoses, trabeculated parenchyma including often thick fibrous bands, and capsular or vascular invasion.90 Because any of these
Nonfunctional Parathyroid Carcinoma
Nonfunctional parathyroid carcinoma is extremely rare. Fewer than 20 cases have been reported in the literature since 1929,101 including a case in the context of FIHP with germline mutation of HRPT2/CDC73.31 Patients are normocalcemic at diagnosis and, in all those in whom it was measured, PTH is within the normal range. About 80% present with a neck mass, and other common findings at presentation include dysphagia, hoarseness or vocal cord paralysis, and dyspnea.101, 102 Grossly, tumors are
Surgical
Most investigators recommend en bloc resection at the initial surgery to offer the best chance for cure. This approach requires recognition of the possibility of malignancy during exploration. Adequate surgical excision requires removal of the ipsilateral thyroid lobe andisthmus, skeletonization of the trachea, and excision of any skeletal muscle intimately related to the tumor. The surgeon must be careful not to rupture the capsule of the tumor to avoid seeding of the surgical field.1 If the
Natural History of Parathyroid Cancer
Following initial surgery, anywhere from 25% to 80% of patients with parathyroid cancer develop local recurrence. Recurrence typically is detected 2 to 4 years after the initial operation, and these patients have a median survival on the order of 5 to 6 years after the initial diagnosis.2, 3, 4, 6, 71, 76, 122 Approximately 25% of patients develop distant metastases at some point during the disease. Rarely, they are present at the time of diagnosis. At the other extreme, metastases have been
Conclusions
Parathyroid carcinoma is a rare endocrine malignancy whose recognition requires a high index of suspicion based on clinical features, such as a palpable neck mass and severe primary HPT. Histologic features can be nonspecific. Diagnosis is definitive when local invasion or lymph node or distant metastases are demonstrated. Somatic mutation of HRPT2/CDC73 is a common finding in sporadic parathyroid carcinomas, and because some 25% of apparently sporadic cases harbor germline HRPT2/CDC73
Acknowledgments
The authors thank Dr Stephen J. Marx for his critical reading of the manuscript, and our colleagues Drs Lee S. Weinstein, Monica C. Skarulis, and Sunita K. Agarwal of the National Institute of Diabetes and Digestive and Kidney Diseases for their ongoing support and encouragement. The Intramural Research Program of the National Cancer Institute and the National Institute of Diabetes and Digestive and Kidney Diseases supported this research.
References (123)
- et al.
A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003
Otolaryngol Head Neck Surg
(2005) - et al.
Parathyroid cancer: biology and management
Surg Oncol
(1999) - et al.
Hyperparathyroidism after irradiation for childhood malignancy
Int J Radiat Oncol Biol Phys
(2009) - et al.
Patterns of chromosomal imbalances in parathyroid carcinomas
Am J Pathol
(2000) - et al.
Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation
Endocr Pract
(2009) - et al.
Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis
Mayo Clin Proc
(2002) - et al.
Comparative genomic hybridization analysis of human parathyroid tumors
Cancer GenetCytogenet
(1998) - et al.
Parathyroid carcinoma in secondary and tertiary hyperparathyroidism
J Am Coll Surg
(2004) - et al.
Natural history of parathyroid carcinomaDiagnosis, treatment, and results
Am J Surg
(1985) - et al.
Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining
Hum Pathol
(1995)
Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases
Hum Pathol
Parathyroid carcinoma: a collective review
Ann Surg
Parathyroid carcinoma: a review of 62 patients
Endocr Rev
Diagnosis and treatment of patients with parathyroid carcinoma: an update and review
World J Surg
Parathyroid carcinoma: clinical and pathologic features in 43 patients
Medicine (Baltimore)
Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection
World J Surg
Trends in the incidence andtreatment of parathyroid cancer in the United States
Cancer
Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base ReportThe American College of Surgeons Commission on Cancer and the American Cancer Society
Cancer
Dose-response relationships for radiation-induced hyperparathyroidism
J Clin Endocrinol Metab
Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy
Radiat Res
Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients
Clin Endocrinol
Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy
J Am Coll Surg
Clinical, biochemical, and pathologic features of radiation-associated hyperparathyroidism
Arch Intern Med
Hyperparathyroidism after neck irradiation
Br J Surg
Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck
J Clin Pathol
Parathyroid carcinoma: two new cases—diagnosis, therapy, and treatment
Laryngoscope
Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome
Surgery
Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome
J Intern Med
Hyperparathyroidism-jaw tumour syndrome
J Intern Med
Familial cystic parathyroid adenomatosis
Ann Intern Med
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
Nature Genet
Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme
Mol Cell Biol
Parafibromin—functional insights
J Intern Med
Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome
J Clin Endocrinol Metab
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)
J Med Genet
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors
J Clin Endocrinol Metab
Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism
J Med Genet
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours
Clin Endocrinol
Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance
J Clin Endocrinol Metab
Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome
Clin Endocrinol
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation
J Bone Miner Res
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism
Endocr Relat Cancer
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
J Med Genet
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors
J Clin Endocrinol Metab
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
N Engl J Med
Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas
Clin Endocrinol
CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors
Endocr Relat Cancer
Aberrant methylation of the HRPT2 gene in parathyroid carcinoma
Ann Otol Rhinol Laryngol
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue
Endocr Relat Cancer
HRPT2 mutational analysis of typical sporadic parathyroid adenomas
J Clin Endocrinol Metab
Cited by (92)
Parathyroid Carcinoma: A National Cancer Database Analysis
2023, Journal of Surgical ResearchParathyroid Carcinoma: An Experience from the Indian Primary Hyperparathyroidism Registry
2021, Endocrine PracticeTumor Volume Can Be Used as a Parameter Indicating the Severity of Disease in Parathyroid Cancer
2021, Endocrine PracticeCitation Excerpt :There were no significant correlations between tumor size and calcium, phosphorus, ALP, PTH, and vitamin D levels. The morbidity and mortality associated with PC are generally because of PTH secretion and hypercalcemia, rather than the tumor size itself.16,33,34 Thus, the current study also showed that tumor size had no effect on disease severity.
A rare case of three years disease free survival in a locally advanced parathyroid carcinoma successfully excised by complete surgical resection
2020, Annals of Medicine and SurgeryCitation Excerpt :Multiple case series suggest the involvement of renal and skeletal disease in up to 50% of patients in parathyroid carcinoma with an incidence of nephrolithiasis and renal insufficiency as high as 56 and 84% respectively [13]. Recent studies also suggest the presence of a palpable cervical mass in about 30–76% of patients while the incidence of completely asymptomatic parathyroid carcinoma described in 7–46% of patients and approximately 25% of patients develop distant metastases at some point during the disease [6,18]. In contrast, our patient had a hormonally functioning parathyroid carcinoma but she did not develop renal or skeletal disease despite advanced age and did not have a palpable neck mass.
Parathyroid carcinoma: Imaging features of initial presentation and recurrence. A single center experience
2024, Neuroradiology JournalCase presentation of the smallest non-functional parathyroid carcinoma and review of the literature
2023, European Archives of Oto-Rhino-Laryngology
The Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute supported this research.
Conflict of Interest Statement: The authors declare that they have no conflicts of interest, or competing financial or personal relationships that could inappropriately influence the content of this article.